OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading

OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading

False or misleading claims and representations in a professional promotion about the efficacy and risks of a prescription drug for high cholesterol are cited in a June 2 Untitled Letter from OPDP to Althera Pharmaceuticals LLC...

 

June 27, 2022 1:52 PM
Read More +

HHS Formally Withdraws SUNSET Final Rule

HHS Formally Withdraws SUNSET Final Rule

HHS has formally withdrawn a Trump administration rule -- the “Securing Updated and Necessary Statutory Evaluations Timely” (SUNSET) final rule -- that threatened to cause many HHS regulations to expire...

June 20, 2022 1:25 PM
Read More +

Reorg, Outreach Efforts Help OPDP to Be More Proactive, User-friendly

Reorg, Outreach Efforts Help OPDP to Be More Proactive, User-friendly

From a staff reorganization to a monthly newsletter to increased collaborations with stakeholders, in 2022 the FDA's OPDP has made a series of moves to make OPDP both more transparent and user-friendly...

 

June 13, 2022 3:32 PM
Read More +

OPDP to Study Risk/Benefit Tradeoff Decisions Made by Consumers, Physicians

OPDP to Study Risk/Benefit Tradeoff Decisions Made by Consumers, Physicians

Understanding the tradeoffs among desirable and undesirable drug product characteristics that consumers and their treating physicians make is the goal of a recently announced Office of Prescription Drug Promotion study...

May 31, 2022 8:50 AM
Read More +

Recent Posts

Medicare Advantage Plans May Promise More but Deliver Less

05, 02, 2022

Read more

IQVIA Drug Spending Report: OOP Costs Increasing, but Net Prices Rising Below Inflation

04, 25, 2022

Read more

Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health

04, 18, 2022

Read more

Upcoming Event

{title}

{body}

Read More +

About Us

CHC

CHC

The Coalition for Healthcare Communication is an organization that promotes the free exchange of scientific and medical information. It is essential that healthcare professionals and the general public receive truthful, accurate information regarding pharmaceuticals, medical products and devices, and patient care.

In addition to white papers and other documents published by the Coalition, you can also find relevant information on current healthcare and health economics issues, as well as policy positions published by government agencies and other professional organizations.